TY - JOUR
T1 - An in vitro model of aneurysmal subarachnoid hemorrhage
T2 - Oxidation of unconjugated bilirubin by cytochrome oxidase
AU - Loftspring, Matthew C.
AU - Wurster, William L.
AU - Pyne-Geithman, Gail J.
AU - Clark, Joseph F.
PY - 2007/9
Y1 - 2007/9
N2 - Aneurysmal subarachnoid hemorrhage is a stroke subtype with high rates of mortality and morbidity. Cerebral vasospasm can lead to ischemic injury or death and is a common complication of aneurysmal subarachnoid hemorrhage, usually occurring 3-9 days afterwards. The cause of vasospasm is not known. Recently, there has been strong evidence that vasoactive oxidation products of bilirubin may be involved. Currently, the factors that lead to bilirubin oxidation are poorly characterized. In this study, we have designed an in vitro model of hemorrhagic stroke in order to investigate conditions that promote the oxidation of bilirubin to form vasoactive compounds. Using our model, we created a basic hematoma system of blood, CSF, and hemeoxygenase-1. We manipulated this system in various ways, incubated it and determined the concentration of vasoactive bilirubin oxidation products that resulted. Conditions where cytochrome oxidase was stimulated caused an increase bilirubin oxidation products (292.6 ± 39.9 μmol/L respectively, vs. 79.3 ± 1.3 μmol/L for the basic reaction, p < 0.05), which was attenuated by cyanide. Our data suggest that bilirubin oxidation products may be produced by oxidation(s) requiring an oxygen-utilizing enzyme like cytochrome oxidase.
AB - Aneurysmal subarachnoid hemorrhage is a stroke subtype with high rates of mortality and morbidity. Cerebral vasospasm can lead to ischemic injury or death and is a common complication of aneurysmal subarachnoid hemorrhage, usually occurring 3-9 days afterwards. The cause of vasospasm is not known. Recently, there has been strong evidence that vasoactive oxidation products of bilirubin may be involved. Currently, the factors that lead to bilirubin oxidation are poorly characterized. In this study, we have designed an in vitro model of hemorrhagic stroke in order to investigate conditions that promote the oxidation of bilirubin to form vasoactive compounds. Using our model, we created a basic hematoma system of blood, CSF, and hemeoxygenase-1. We manipulated this system in various ways, incubated it and determined the concentration of vasoactive bilirubin oxidation products that resulted. Conditions where cytochrome oxidase was stimulated caused an increase bilirubin oxidation products (292.6 ± 39.9 μmol/L respectively, vs. 79.3 ± 1.3 μmol/L for the basic reaction, p < 0.05), which was attenuated by cyanide. Our data suggest that bilirubin oxidation products may be produced by oxidation(s) requiring an oxygen-utilizing enzyme like cytochrome oxidase.
KW - Bilirubin
KW - Bilirubin oxidation products
KW - Cerebral vasospasm
KW - Oxidative stress
KW - Stroke
KW - Subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=34548272996&partnerID=8YFLogxK
U2 - 10.1111/j.1471-4159.2007.04667.x
DO - 10.1111/j.1471-4159.2007.04667.x
M3 - Article
C2 - 17539918
AN - SCOPUS:34548272996
SN - 0022-3042
VL - 102
SP - 1990
EP - 1995
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 6
ER -